A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO
Trial details
- Registry ID
- NCT07734844
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as Eylea
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTONCT07734844 | KOD | Phase 3 | Recruiting | 2028-08-31Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |